CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 99 enrolled
Drug / intervention
Minocycline +2 moredrug
Likely dose
Minocycline 100 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01429272
NCT01429272Phase 3Completed
CompareCT.gov

Minocycline and Aspirin in the Treatment of Bipolar Depression

Laureate Institute for Brain Research, Inc.·interventional·Posted Sep 7, 2011·Updated Jan 11, 2018

In Brief

A Phase 3 clinical trial evaluating Minocycline, Aspirin, and 1 other intervention for Bipolar Disorder Depression. Completed, enrolled 99 participants across 3 sites.

Detailed Summary

The purpose of this study is to determine whether minocycline and aspirin are effective in the treatment of depression in individuals with bipolar disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder Depression
CountriesUnited States
CollaboratorsStanley Medical Research Institute, University of Oklahoma

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 7, 2011
Enrollment StartSep 1, 2011
Primary CompletionAug 1, 2015
Study CompletionSep 1, 2015
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 14.8 years ago

Interventions

Minocyclinedrug

100 mg po bid for 6 weeks

Aspirindrug

81 mg po bid for 6 weeks

placebodrug

placebo for minocycline and/or aspirin